Microorganisms and methods for production of specific length fatty alcohols and related compounds

US10513716B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10513716-B2
Application numberUS-201314053381-A
CountryUS
Kind codeB2
Filing dateOct 14, 2013
Priority dateOct 15, 2012
Publication dateDec 24, 2019
Grant dateDec 24, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides non-naturally occurring microbial organisms containing a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbial organisms selectively produce a fatty alcohol, fatty aldehyde or fatty acid of a specified length. Also provided are non-naturally occurring microbial organisms having a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbial organisms further include an acetyl-CoA pathway. In some aspects, the microbial organisms of the invention have select gene disruptions or enzyme attenuations that increase production of fatty alcohols, fatty aldehydes or fatty acids. The invention additionally provides methods of using the above microbial organisms to produce a fatty alcohol, a fatty aldehyde or a fatty acid.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-naturally occurring microbial organism for production of a compound of Formula (VI), (X) or (XIV): wherein at least 80% of the compound produced by the microbial organism is C 7 linear alkyl at R 1 , wherein the microbial organism comprises a malonyl-CoA independent fatty acyl-CoA elongation (MI-FAE) cycle and a termination pathway, wherein said MI-FAE cycle comprises one or more thiolase, one or more 3-oxoacyl-CoA reductase, one or more 3-hydroxyacyl-CoA dehydratase, and one or more enoyl-CoA reductase, wherein said termination pathway comprises a pathway selected from: (1) 1H; (2) 1K and 1L; (3) 1E and 1N; (4) 1K, 1J, and 1N; (5) 1E; (6) 1K and 1J; (7) 1H and 1N; (8) 1K, 1L, and 1N; (9) 1E and 1F; (10) 1K, 1J, and 1F; (11) 1H, 1N, and 1F; (12) 1K, 1L, 1N, and 1F; and (13) 1G, wherein 1E is an acyl-CoA reductase (aldehyde forming), wherein 1F is an alcohol dehydrogenase, wherein 1G is an acyl-CoA reductase (alcohol forming), wherein 1H is an acyl-CoA hydrolase, acyl-CoA transferase or acyl-CoA synthase, wherein 1J is an acyl-ACP reductase, wherein 1K is an acyl-CoA:ACP acyltransferase, wherein 1L is a thioesterase, wherein 1N is an aldehyde dehydrogenase (acid forming) or a carboxylic acid reductase, wherein an enzyme of the MI-FAE cycle or termination pathway is encoded by at least one exogenous nucleic acid and is expressed in a sufficient amount to produce the compound of Formula (VI), (X) or (XIV), wherein one or more enzymes of the MI-FAE cycle are each independently selective for a compound of Formula (II), propionyl-CoA or acetyl-CoA as a substrate: wherein R 1a is no greater than C 7 linear alkyl R 3 is H, OH, or oxo (═O); R 4 is S-CoA; and represents a single or double bond with the proviso that the valency of the carbon atom to which R 3 is attached is four; and wherein one or more enzymes of the termination pathway are each independently selective for the compound of Formula (II) as a substrate wherein: R 1a is no less than C 7 linear alkyl; R 3 is H; and R 4 is S-CoA, ACP, OH or H. 2. A non-naturally occurring microbial organism for production of a compound of Formula (VI), (X) or (XIV): wherein at least 80% of the compound produced by the microbial organism is C 9 linear alkyl at R 1 , wherein the microbial organism comprises a malonyl-CoA independent fatty acyl-CoA elongation (MI-FAE) cycle and a termination pathway, wherein said MI-FAE cycle comprises one or more thiolase, one or more 3-oxoacyl-CoA reductase, one or more 3-hydroxyacyl-CoA dehydratase, and one or more enoyl-CoA reductase, wherein said termination pathway comprises a pathway selected from: (1) 1H; (2) 1K and 1L; (3) 1E and 1N; (4) 1K, 1J, and 1N; (5) 1E; (6) 1K and 1J; (7) 1H and 1N; (8) 1K, 1L, and 1N; (9) 1E and 1F; (10) 1K, 1J, and 1F; (11) 1H, 1N, and 1F; (12) 1K, 1L, 1N, and 1F; and (13) 1G, wherein 1E is an acyl-CoA reductase (aldehyde forming), wherein 1F is an alcohol dehydrogenase, wherein 1G is an acyl-CoA reductase (alcohol forming), wherein 1H is an acyl-CoA hydrolase, acyl-CoA transferase or acyl-CoA synthase, wherein 1J is an acyl-ACP reductase, wherein 1K is an acyl-CoA:ACP acyltransferase, wherein 1L is a thioesterase, wherein 1N is an aldehyde dehydrogenase (acid forming) or a carboxylic acid reductase, wherein an enzyme of the MI-FAE cycle or termination pathway is encoded by at least one exogenous nucleic acid and is expressed in a sufficient amount to produce the compound of Formula (VI), (X) or (XIV), wherein one or more enzymes of the MI-FAE cycle are each independently selective for a compound of Formula (II), propionyl-CoA or acetyl-CoA as a substrate: wherein R 1a is no greater than C 9 linear alkyl; R 3 is H, OH, or oxo (═O); R 4 is S-CoA; and represents a single or double bond with the proviso that the valency of the carbon atom to which R 3 is attached is four; and wherein one or more enzymes of the termination pathway are each independently selective for the compound of Formula (II) as a substrate wherein: R 1a is no less than C 9 linear alkyl; R 3 is H; and R 4 is S-CoA, ACP, OH or H. 3. A non-naturally occurring microbial organism for production of a compound of Formula (VI), (X) or (XIV): wherein at least 80% of the compound produced by the microbial organism is C 11 linear alkyl at R 1 , wherein the microbial organism comprises a malonyl-CoA independent fatty acyl-CoA elongation (MI-FAE) cycle and a termination pathway, wherein said MI-FAE cycle comprises one or more thiolase, one or more 3-oxoacyl-CoA reductase, one or more 3-hydroxyacyl-CoA dehydratase, and one or more enoyl-CoA reductase, wherein said termination pathway comprises a pathway selected from: (1) 1H; (2) 1K and 1L; (3) 1E and 1N; (4) 1K, 1J, and 1N; (5) 1E; (6) 1K and 1J; (7) 1H and 1N; (8) 1K, 1L, and 1N; (9) 1E and 1F; (10) 1K, 1J, and 1F; (11) 1H, 1N, and 1F; (12) 1K, 1L, 1N, and 1F; and (13) 1G, wherein 1E is an acyl-CoA reductase (aldehyde forming), wherein 1F is an alcohol dehydrogenase, wherein 1G is an acyl-CoA reductase (alcohol forming), wherein 1H is an acyl-CoA hydrolase, acyl-CoA transferase or acyl-CoA synthase, wherein 1J is an acyl-ACP reductase, wherein 1K is an acyl-CoA:ACP acyltransferase, wherein 1L is a thioesterase, wherein 1N is an aldehyde dehydrogenase (acid forming) or a carboxylic acid reductase, wherein an enzyme of the MI-FAE cycle or termination pathway is encoded by at least one exogenous nucleic acid and is expressed in a sufficient amount to produce the compound of Formula (VI), (X) or (XIV), wherein one or more enzymes of the MI-FAE cycle are each independently selective for a compound of Formula (II), propionyl-CoA or acetyl-CoA as a substrate: wherein R 1a is no greater than C 11 linear alkyl; R 3 is H, OH, or oxo (═O); R 4 is S-CoA; and represents a single or double bond with the proviso that the valency of the carbon atom to which R 3 is attached is four; and wherein one or more enzymes of the termination pathway are each independently selective for the compound of Formula (II) as a substrate wherein: R 1a is no less than C 11 linear alkyl; R 3 is H; and R 4 is S-CoA, ACP, OH or H. 4. A non-naturally occurring microbial organism for production of a compound of Formula (VI), (X) or (XIV): wherein at least 80% of the compound produced by the microbial organism is C 13 linear alkyl at R 1 , wherein the microbial organism comprises a malonyl-CoA independent fatty acyl-CoA elongation (MI-FAE) cycle and a termination pathway, wherein s

Assignees

Inventors

Classifications

  • Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring · CPC title

  • acting on the aldehyde or oxo group of donors (1.2) · CPC title

  • Succinate-semialdehyde dehydrogenase (acetylating) (1.2.1.76) · CPC title

  • C12P7/6409Primary

    Fatty acids · CPC title

  • C12P7/04Primary

    acyclic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10513716B2 cover?
The invention provides non-naturally occurring microbial organisms containing a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbial organisms selectively produce a fatty alcohol, fatty aldehyde or fatty acid of a specified length. Also provided are non-naturally occurring microbial organisms having a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbi…
Who is the assignee on this patent?
Genomatica Inc
What technology area does this patent fall under?
Primary CPC classification C12P7/6409. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).